ISRCTN25571720已完成未知
Effect of 2 versus 3 pneumococcal conjugate vaccinations Prevnar on nasopharyngeal carriage, transmission and herd immunity; a randomized, controlled study.
niversity Medical Centre Utrecht (UMCU) (Netherlands)0 个研究点目标入组 1,003 人开始时间: 2005年12月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,003
研究概览
简要总结
- 2009 results in: https://www.ncbi.nlm.nih.gov/pubmed/19584345 (added 31/05/2019) 2. 2010 results in: https://www.ncbi.nlm.nih.gov/pubmed/20823436 (added 31/05/2019) 3. 2011 results in: https://www.ncbi.nlm.nih.gov/pubmed/21695210 (added 31/05/2019) 4. 2011 results in: https://www.ncbi.nlm.nih.gov/pubmed/21813135 (added 31/05/2019) 5. 2013 results in: https://www.ncbi.nlm.nih.gov/pubmed/24120678 (added 31/05/2019) 6. 2014 results in: https://www.ncbi.nlm.nih.gov/pubmed/24447437 (added 31/05/2019) 7. 2014 results in: https://www.ncbi.nlm.nih.gov/pubmed/24921688 (added 31/05/2019) 8. 2014 results in: https://www.ncbi.nlm.nih.gov/pubmed/25329446 (added 31/05/2019)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1000 healthy newborns (and family members) who will receive childhood vaccinations according to the national vaccination program, starting at 2 months of age.
排除标准
- •Exclusion from the national vaccination program because of the presence of a medical condition requiring treatment that can interfere with the results of vaccinations, known of suspected allergy to components of the vaccine, known or suspected immunodeficiency disease other than IgA or IgG-subclass deficiency, previous treatment with plasma or immunoglobulins, previous vaccinations other than hepatitis B vaccinations, coagulations disorders
研究者
相似试验
已完成
不适用
Effect of 2 versus 3 pneumococcal conjugate vaccinations Prevnar on nasopharyngeal carriage, transmission and herd immunity;a randomized, controlled study.Prevention of invasive pneumococcal disease in healthy infantsNL-OMON26724Prof Dr EAM SandersUniversity Medical Center UtrechtDepartment of Pediatric ImmunologyHP 06.063.0Lundlaan 6POBox 850903508 AB Utrecht, The NetherlandsPhone 31 30 2504000Fax 31 30 2505350email l.sanders@umcutrecht.nl1,000
已完成
不适用
Evaluation of pneumococcal conjugate vaccine (Prevenar) in patients with myeloma and chronic lymphocytic leukaemiaCancerISRCTN21541376Central Manchester and Manchester Children's Hospital (UK)97
进行中（未招募）
1 期
Evaluation of pneumococcal conjugate vaccine (Prevenar) in patients with myeloma and chronic lymphocytic leukaemia - Pneumococcal conjugate vaccination in Haematology patients: Version 1Pneumococcal disease is a common form of meningitis, septicaemia and pneumonia. Those individuals at highest risk include children, the elderly and persons whose immune systems are impaired. This latter group is diverse includes patients with the haematological disorders myeloma and chronic lymphocytic leukaemia in whom infections are a leading cause of death.EUCTR2005-003761-16-GBDepartment of R & D, Central Manchester and Manchester Children's Hospital NHS Trust97
已完成
3 期
Effect of Two Versus Three Pneumococcal Conjugate VaccinationsStreptococcus Pneumoniae InfectionNCT00189020UMC Utrecht1,005
尚未招募
不适用
Efficacy of pneumococcal conjugate vaccine in preventing acquisition and carriage of pneumococcal vaccine serotypes in Tanzanian children with human immunodeficiency virus/ acquired immunodeficiency syndrome (HIV/AIDS)Pneumococcal diseaseHIV/AIDSPublic Health - EpidemiologyInfection - Studies of infection and infectious agentsACTRN12610000999033Prof Robert Booy216